Menu
Search

News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

See all news

DTN Highlights

See DTN Highlights

  • Quantum Design completes acquisition of Qnami

    Quantum Design has acquired Qnami, a leading developer of diamond-based quantum sensing technologies with its roots at the Physics Department of the University of Basel.…

    startupticker.ch

    • Quantum Design acquired Qnami, a diamond-based quantum sensing company from University of Basel, strengthening quantum materials and nanomagnetism research.
    • Qnami's nitrogen-vacancy center technology enables nanoscale magnetic imaging for materials, semiconductors, and spintronics in academia and industry.
    • The merger will accelerate Qnami's growth while leveraging Quantum Design's 40-year track record and presence in 20+ countries.
    startupticker.ch: Quantum Design completes acquisition of Qnami

  • NUCLIDIUM's Series B reaches CHF 105 million with latest extension

    Basel-based biotech NUCLIDIUM has closed an oversubscribed CHF 26 million Series B extension, bringing the round to CHF 105 million, to advance its copper-based cancer…

    startupticker.ch

    • NUCLIDIUM raised CHF 26M in Series B extension, bringing total Series B funding to CHF 105M for copper-based cancer diagnostics and therapy.
    • Lead programs NU101 and NU201 show superior tumor detection and higher tumor-to-background ratios versus approved clinical tracers.
    • Funding will support Phase 1/2 trials expansion and global manufacturing scale-up for radiotheranostic cancer treatments.
    startupticker.ch: NUCLIDIUM's Series B reaches CHF 105 million with latest extension

  • Terra Quantum changes its IPO plans

    Following an initial announcement in April regarding an IPO via SPAC, Terra Quantum has now presented a new plan involving a different shell company and…

    startupticker.ch

    • Terra Quantum valued at $3.6B in SPAC merger with Axiom Intelligence, targeting Nasdaq listing under 'TQ' in H2 2026.
    • Terra Quantum offers integrated stack: quantum computing, quantum-inspired optimization, AI, and quantum cybersecurity.
    • Terra Quantum shareholders retain ~92% post-closing; transaction expected to raise $190M in gross proceeds.
    startupticker.ch: Terra Quantum changes its IPO plans

  • AI firm Visium secures funds to scale across Europe and US

    Visium has closed its first institutional funding round after eight years as a bootstrapped company. Now employing 100 people across Europe, the firm provides AI…

    startupticker.ch

    • Visium employs 100 people across Europe and delivered 250+ AI and data projects to regulated industry clients including Roche, Novartis, and DSM-Firmenich.
    • Angel investors include Hugging Face co-founder Thomas Wolf, Silo AI founder Peter Sarlin, and other AI and tech company builders.
    startupticker.ch: AI firm Visium secures funds to scale across Europe and US

  • InSphero acquires PhenoVista to expand US presence

    InSphero has acquired PhenoVista Biosciences, a California-based contract research organization specializing in imaging-based laboratory assays. The deal expands the Swiss company's presence in the United…

    startupticker.ch

    • InSphero acquired PhenoVista Biosciences to combine 3D spheroid models with high-content imaging and AI analytics for drug discovery.
    • The acquisition strengthens InSphero's US presence and expands capabilities in neuroscience, oncology, fibrosis, and safety testing.
    • The deal reflects growing demand for New Approach Methodologies to reduce animal testing in drug development, backed by FDA and NIH.
    startupticker.ch: InSphero acquires PhenoVista to expand US presence

  • DePoly's new plant sparks high demand

    DePoly has secured contracts worth a total of CHF 50 million for its demonstration plant in Monthey, which is currently in the final stages of…

    startupticker.ch

    • DePoly secured CHF 50 million in contracts for its plastic recycling plant in Monthey, Switzerland.
    • The Monthey plant will process 500 tonnes of PET/polyester waste yearly and start operations summer 2024.
    • DePoly recycles mixed post-consumer and post-industrial textile and packaging waste into usable polymers.
    startupticker.ch: DePoly's new plant sparks high demand

  • Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round

    Neurosoft Bioelectronics, a Swiss neurotechnology startup developing scalable and soft brain-computer interfaces (BCIs), today announced that it has raised a $7.5 million oversubscribed seed financing…

    startupticker.ch

    • Neurosoft raised $7.5M in seed funding for minimally invasive brain-computer interfaces 1,000x more compliant than existing options.
    • The company tested its soft electrode platform in 10 patients across two trials and seeks US commercialization of its first BCI.
    • Neurosoft is building a cortical foundation model using neural data from its implants to advance brain interfaces for neurological conditions.
    startupticker.ch: Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round

  • Fruitful AI closes strategic investment round

    40Factory announces a strategic investment in FruitfulAI AG, a Zurich-based startup specializing in AI Machine Vision technologies applied to industrial environments. The investment aims to…

    startupticker.ch

    • 40Factory invests in FruitfulAI AG to add AI video intelligence to its Industrial IoT platform for manufacturing insights.
    • The solution optimizes production efficiency, improves quality control, enhances operator safety, and reduces intervention times.
    • 40Factory's CEO joins FruitfulAI's board to create a unified platform combining machine data, process data, and video analytics.
    startupticker.ch: Fruitful AI closes strategic investment round

  • Market momentum for thriving Kitro

    After temporarily losing most of its customers during the COVID-19 pandemic, Kitro has shown resilience, regaining momentum on market, driven by a growing awareness of…

    startupticker.ch

    • Kitro's AI food waste system serves 500+ kitchens across 40 countries, reducing waste by 20-50% and saving over 3 million meals.
    • Marriott, Four Seasons, and Hyatt converted Kitro pilots to long-term contracts, with expansion into cruise and healthcare sectors.
    • Kitro plans expansion across Iberia, Europe, and North America to become the industry standard for kitchen resource management.
    startupticker.ch: Market momentum for thriving Kitro

  • New MiFID license opens European Market to Taurus

    Taurus SA, a FINMA-regulated securities firm and a leader in digital asset infrastructure technology solutions, announced that its Cyprus-based subsidiary, Taurus (Europe) Ltd, has been…

    startupticker.ch

    • Taurus (Europe) Ltd obtained a MiFID license from Cyprus's CySEC, enabling digital asset services across all 27 EU jurisdictions.
    • The MiFID license allows Taurus to offer tokenized DLT financial instruments, complementing its custody and tokenization platform.
    • Taurus appointed experienced independent board members, including a former Swissquote COO, to oversee its EU expansion.
    startupticker.ch: New MiFID license opens European Market to Taurus

  • Swiss Biotech Report confirms the sector’s strong performance

    In 2025 the Swiss biotech industry set two new records. Privately funded companies attracted CHF 1.15 million, thanks to start-ups led by convincing, experienced teams.…

    startupticker.ch

    • Swiss biotech raised record CHF 1.15 billion in 2025 funding, with investors favoring experienced teams with proven success.
    • Total revenues hit CHF 7.5 billion in 2025, driven by more companies commercializing and growing CDMO service demand.
    • Platform companies can now stay independent by selling late-stage assets instead of pursuing IPOs, a new market trend.
    startupticker.ch: Swiss Biotech Report confirms the sector’s strong performance

  • Windward Bio secures USD 165 million to advance clinical trials

    Windward Bio, a private, clinical-stage biotechnology company focussing on immunological diseases, announced an upsized $165M crossover financing. Since launching in January 2025, Windward Bio has…

    startupticker.ch

    • Windward Bio raised $165M in crossover financing to advance WIN378, an anti-TSLP antibody with potential twice-yearly dosing for asthma and COPD.
    • WIN027, a bispecific antibody targeting TSLP and IL-13, is in Phase 1 with proof-of-concept studies starting Q4 2026 in respiratory and dermatology.
    • Windward expects multiple clinical readouts within 12 months: Phase 2 asthma data in H2 2026 and Phase 1 WIN027 data by end of 2026.
    startupticker.ch: Windward Bio secures USD 165 million to advance clinical trials